Mobile Menu

Navigation

  • About us
    • Our Company
    • Management
    • Board of Directors
    • Advisory Board
    • Careers
  • Technology
    • Platform
    • IP
  • Pipeline
  • Partners
    • Collaborations
    • Grants & Awards
  • Investors
  • Newsroom
    • Press Releases
    • Events
    • Scientific Publications & Reviews
  • Contact
  • Search
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Virometix AG

Using the tools of nanotechnology and synthetic biology

  • About us
    • Our Company
    • Management
    • Board of Directors
    • Advisory Board
    • Careers
  • Technology
    • Platform
    • IP
  • Pipeline
  • Partners
    • Collaborations
    • Grants & Awards
  • Investors
  • Newsroom
    • Press Releases
    • Events
    • Scientific Publications & Reviews
  • Contact
  • Search

Collaborations

Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human diseases.

Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.

For partnering enquiries, please contact us at info@virometix.com. Alternatively, you can meet us at the following upcoming conferences:

> Events

Grants & Awards

Our awards include the following

  • Privacy Statement
  • Site Notice

Site Footer

LinkedIn

  • LinkedIn

Virometix AG · Wagistrasse 14 · CH-8952 Schlieren · +41 (0) 43 433 86 60 · info@virometix.com

Copyright © 2022 · Virometix AG · created by cloudWEB

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. more

Ok